Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPX-01 in moderate to severe inflammatory acne vulgaris
NCT02946788Phase 2Completed
- Sponsor
- BioPharmX
- Start
- Mar 2017
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 2, open-label trial of BPX-01 vehicle gel in acne vulgaris, sponsored by BioPharmX. Primary endpoint: Change From Baseline in Inflammatory Lesion Counts at 12 weeks. Started Mar 2017; status: completed.
02
Drugs
BPX-01 vehicle gel
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02946788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02946788.